How do you diagnose leukemia in a patient with leukocytosis (elevated white blood cell count) and thrombocytosis (elevated platelet count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To diagnose leukemia in a patient with a white blood cell count of 35,000/μL and platelet count of 1,150,000/μL, I would recommend immediate bone marrow aspirate and biopsy, as well as peripheral blood films, to identify the clonal proliferation of myeloid cells and specific genetic abnormalities, as outlined in the ESMO clinical practice guidelines for diagnosis, treatment, and follow-up of acute myeloblastic leukaemias in adult patients 1. The diagnostic workup should include:

  • Immunophenotyping of peripheral blood and bone marrow aspirates to characterize the cell populations
  • Cytogenetics and molecular genetics, including PCR and FISH techniques, to identify specific genetic abnormalities
  • Routine chemistry, including liver and kidney parameters, to assess for any potential organ dysfunction
  • Coagulation profile to evaluate the risk of bleeding or thrombotic complications
  • Radiology, including a dental survey, CT scan of chest and abdomen, or chest X-ray and abdominal ultrasound, to assess for any potential extramedullary disease The patient's elevated white blood cell count and extreme thrombocytosis raise concern for potential complications, such as thrombosis or hemorrhage, and require urgent hematology consultation. The diagnosis of leukemia relies on identifying the clonal proliferation of myeloid cells and specific genetic abnormalities, and the diagnostic workup should be guided by the most recent and highest quality evidence, as outlined in the ESMO clinical practice guidelines 1.

From the Research

Diagnostic Approach to Leukemia

The patient's symptoms and laboratory results, including a white blood cell (WBC) count of 35 and a platelet count of 1150, suggest the possibility of leukemia. To diagnose leukemia, the following steps can be taken:

  • A complete blood count (CBC) is usually the initial test, which can reveal leukocytosis and other abnormally elevated or depressed cell lines, as seen in this patient 2.
  • Further examination of the bone marrow or peripheral blood is necessary to confirm the diagnosis of leukemia 2.
  • Immunophenotyping, karyotype analysis, and molecular genetic testing may also be performed to determine the specific subtype of leukemia 3.

Laboratory Testing

Laboratory testing is crucial in the diagnosis of leukemia. The following tests may be performed:

  • Complete blood count (CBC) to evaluate the patient's blood cell counts, including WBC, red blood cell (RBC), and platelet counts 4.
  • Bone marrow biopsy or aspiration to examine the bone marrow for abnormal cells 2.
  • Immunophenotyping to determine the specific type of leukemia cells present 3.
  • Karyotype analysis to identify any genetic abnormalities, such as the Philadelphia chromosome, which is characteristic of chronic myeloid leukemia (CML) 5, 6.

Subtypes of Leukemia

There are several subtypes of leukemia, including:

  • Acute lymphoblastic leukemia (ALL)
  • Acute myelogenous leukemia (AML)
  • Chronic lymphocytic leukemia (CLL)
  • Chronic myeloid leukemia (CML) Each subtype has distinct characteristics and requires specific diagnostic testing and treatment approaches 2, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.